What are the current odds for "Hantavirus vaccine in 2026? "?

As of July 2026, prediction markets give this a 5.5% probability of resolving Yes. This market is trading on Polymarket with $128.3K in total volume.

Where can I trade on "Hantavirus vaccine in 2026? "?

This market is available on Polymarket. You can trade Yes shares at 5.5% or No shares at 94.5%. The market has $29.8K in liquidity.

When does this prediction market close?

This market is scheduled to resolve 5 months (Dec 31, 2026). After resolution, winning shares pay out $1.00 each.

Polymarketother

Hantavirus vaccine in 2026?

Updated 23 hr ago

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Currently 5.5% on Polymarket, with $128,263 in total trading volume.

Current Probability

5.5%

Trade on Polymarket

YesNo

If Yes wins

$18.18 return per $1

If No wins

$1.06 return per $1

↓ Compare across platforms Trending markets →

Resolution Criteria

From Polymarket

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.

View full rules

Listed on Polymarket May 4, 2026 · Resolves Dec 31, 2026